149 related articles for article (PubMed ID: 37678101)
21. Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy.
Quattrone A; Crasà M; Morelli M; Vescio B; Augimeri A; Gramigna V; Quattrone A
Parkinsonism Relat Disord; 2022 Jun; 99():84-90. PubMed ID: 35642995
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
[TBL] [Abstract][Full Text] [Related]
23. Global Acoustic Speech Temporal Characteristics for Mandarin Speakers With Parkinson's Disease During Syllable Repetition and Passage Reading.
He D; Feenaughty L; Wan Q
Am J Speech Lang Pathol; 2023 Sep; 32(5):2232-2244. PubMed ID: 37625136
[TBL] [Abstract][Full Text] [Related]
24. "Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.
Necpál J; Borsek M; Jeleňová B
Neurol Sci; 2021 Dec; 42(12):4927-4936. PubMed ID: 34532773
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.
Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A
J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175
[TBL] [Abstract][Full Text] [Related]
26. The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson's disease (PD).
Swallow DMA; Counsell CE
J Neurol; 2023 Jul; 270(7):3464-3474. PubMed ID: 36971841
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
Archer DB; Bricker JT; Chu WT; Burciu RG; McCracken JL; Lai S; Coombes SA; Fang R; Barmpoutis A; Corcos DM; Kurani AS; Mitchell T; Black ML; Herschel E; Simuni T; Parrish TB; Comella C; Xie T; Seppi K; Bohnen NI; Müller ML; Albin RL; Krismer F; Du G; Lewis MM; Huang X; Li H; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
Lancet Digit Health; 2019 Sep; 1(5):e222-e231. PubMed ID: 33323270
[TBL] [Abstract][Full Text] [Related]
28. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
Talai AS; Sedlacik J; Boelmans K; Forkert ND
Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
[TBL] [Abstract][Full Text] [Related]
29. Combined blood Neurofilament light chain and third ventricle width to differentiate Progressive Supranuclear Palsy from Parkinson's Disease: A machine learning study.
Bianco MG; Cristiani CM; Scaramuzzino L; Sarica A; Augimeri A; Chimento I; Buonocore J; Parrotta EI; Quattrone A; Cuda G; Quattrone A
Parkinsonism Relat Disord; 2024 Jun; 123():106978. PubMed ID: 38678852
[TBL] [Abstract][Full Text] [Related]
30. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy.
Suzuki M; Hashimoto M; Yoshioka M; Murakami M; Kawasaki K; Urashima M
BMC Neurol; 2011 Dec; 11():157. PubMed ID: 22192419
[TBL] [Abstract][Full Text] [Related]
31. Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.
Neely KA; Planetta PJ; Prodoehl J; Corcos DM; Comella CL; Goetz CG; Shannon KL; Vaillancourt DE
PLoS One; 2013; 8(3):e58403. PubMed ID: 23505500
[TBL] [Abstract][Full Text] [Related]
32. Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages.
Amboni M; Ricciardi C; Picillo M; De Santis C; Ricciardelli G; Abate F; Tepedino MF; D'Addio G; Cesarelli G; Volpe G; Calabrese MC; Cesarelli M; Barone P
Sci Rep; 2021 Apr; 11(1):9297. PubMed ID: 33927317
[TBL] [Abstract][Full Text] [Related]
33. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant.
Gatto RG; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Dickson DW; Josephs KA; Whitwell JL
Neuroimage Clin; 2022; 35():103030. PubMed ID: 35597031
[TBL] [Abstract][Full Text] [Related]
34. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
[TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis between Parkinson's disease and atypical parkinsonism based on gait and postural instability: Artificial intelligence using an enhanced weight voting ensemble model.
Song J; Kim J; Lee MJ; Ahn JH; Lee DY; Youn J; Chung MJ; Kim Z; Cho JW
Parkinsonism Relat Disord; 2022 May; 98():32-37. PubMed ID: 35447488
[TBL] [Abstract][Full Text] [Related]
36. PTPRC Expression in Blood is Downregulated in Parkinson's and Progressive Supranuclear Palsy Disorders.
Bottero V; Santiago JA; Potashkin JA
J Parkinsons Dis; 2018; 8(4):529-537. PubMed ID: 30248063
[TBL] [Abstract][Full Text] [Related]
37. Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
Ondo W; Warrior D; Overby A; Calmes J; Hendersen N; Olson S; Jankovic J
Arch Neurol; 2000 Oct; 57(10):1464-9. PubMed ID: 11030799
[TBL] [Abstract][Full Text] [Related]
38. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M
Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
